Trials / Completed
CompletedNCT04983940
Patient Satisfaction After Switching to Oral Testosterone Undecanoate
Patient Satisfaction After Switching to Oral Testosterone Undecanoate in Men Currently on Testosterone Therapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to evaluate patient satisfaction with an oral testosterone agent, Jatenzo, compared to other forms of testosterone therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Jatenzo | 237 mg soft gel capsule taken twice a day by mouth with food. |
Timeline
- Start date
- 2021-06-18
- Primary completion
- 2023-04-06
- Completion
- 2023-04-06
- First posted
- 2021-07-30
- Last updated
- 2023-12-14
- Results posted
- 2023-12-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04983940. Inclusion in this directory is not an endorsement.